Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,078 | 21,260 | 11,700 | 15,770 | 11,325 |
| Marketable Securities | 143,592 | 69,830 | 50,960 | 59,320 | 58,595 |
| Receivables | 5,974 | 0 | 860 | 190 | 1,329 |
| Other current assets | 1,761 | 3,720 | 2,110 | 1,090 | 841 |
| TOTAL | $172,405 | $94,810 | $65,630 | $76,370 | $72,090 |
| Non-Current Assets | |||||
| PPE Net | 11,300 | 11,180 | 10,890 | 8,840 | 3,546 |
| Investments And Advances | 0 | 0 | 1,410 | 3,340 | 0 |
| Intangibles | 362 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,895 | 3,220 | 2,570 | 3,330 | 2,319 |
| TOTAL | $13,557 | $14,400 | $14,870 | $15,510 | $5,865 |
| Total Assets | $185,962 | $109,220 | $80,520 | $91,900 | $77,955 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 149 | 140 | 140 | 870 | 0 |
| Accounts payable and accrued liabilities | 1,065 | 2,440 | 2,480 | 1,820 | 800 |
| Accrued Expenses | 11,135 | 5,060 | 2,070 | 2,750 | 1,565 |
| Other current liabilities | N/A | 150 | 160 | 1,910 | 919 |
| TOTAL | $14,959 | $8,640 | $5,560 | $7,370 | $4,067 |
| Non-Current Liabilities | |||||
| Long Term Debt | 162 | 310 | 460 | 720 | 0 |
| Deferred Revenues | 1,172 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,622 | 1,070 | 490 | 0 | 0 |
| TOTAL | $7,795 | $4,200 | $2,980 | $1,370 | $1,121 |
| Total Liabilities | $22,754 | $12,860 | $8,570 | $8,750 | $5,188 |
| Shareholders' Equity | |||||
| Common Shares | 25 | 20 | 10 | 88,600 | 83,251 |
| Retained earnings | -70,480 | -41,670 | -24,850 | -4,890 | -10,021 |
| Other shareholders' equity | 98 | -790 | -270 | -560 | -463 |
| TOTAL | $163,208 | $96,350 | $71,950 | $83,150 | $72,767 |
| Total Liabilities And Equity | $185,962 | $109,210 | $80,520 | $91,900 | $77,955 |